Literature DB >> 23504353

May oxidative stress contribute to autoimmune hepatitis pathogenesis, and can antioxidants be of value as adjuvant therapy for refractory patients?

Ricardo Moreno-Otero.   

Abstract

Entities:  

Mesh:

Year:  2013        PMID: 23504353     DOI: 10.1007/s10620-013-2622-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  11 in total

Review 1.  Introduction to NF-kappaB: players, pathways, perspectives.

Authors:  T D Gilmore
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

Review 2.  Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

3.  S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes.

Authors:  P L Majano; C García-Monzón; E R García-Trevijano; F J Corrales; J Cámara; P Ortiz; J M Mato; M A Avila; R Moreno-Otero
Journal:  J Hepatol       Date:  2001-12       Impact factor: 25.083

4.  S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial.

Authors:  J M Mato; J Cámara; J Fernández de Paz; L Caballería; S Coll; A Caballero; L García-Buey; J Beltrán; V Benita; J Caballería; R Solà; R Moreno-Otero; F Barrao; A Martín-Duce; J A Correa; A Parés; E Barrao; I García-Magaz; J L Puerta; J Moreno; G Boissard; P Ortiz; J Rodés
Journal:  J Hepatol       Date:  1999-06       Impact factor: 25.083

5.  S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.

Authors:  Jordan J Feld; Apurva A Modi; Ramy El-Diwany; Yaron Rotman; Emmanuel Thomas; Golo Ahlenstiel; Rachel Titerence; Christopher Koh; Vera Cherepanov; Theo Heller; Marc G Ghany; Yoon Park; Jay H Hoofnagle; T Jake Liang
Journal:  Gastroenterology       Date:  2010-09-17       Impact factor: 22.682

6.  Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C.

Authors:  Matteo Vidali; Marie-Francoise Tripodi; Alesandra Ivaldi; Rosa Zampino; Giuseppa Occhino; Luciano Restivo; Salvatore Sutti; Aldo Marrone; Giuseppe Ruggiero; Emanuele Albano; Luigi E Adinolfi
Journal:  J Hepatol       Date:  2007-12-03       Impact factor: 25.083

7.  Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis.

Authors:  Paloma Sanz-Cameno; Jesús Medina; Luisa García-Buey; Asunción García-Sánchez; María J Borque; Samuel Martín-Vílchez; Carlos Gamallo; E Anthony Jones; Ricardo Moreno-Otero
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

Review 8.  Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

9.  N-Acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes.

Authors:  Pedro Lorenzo Majano; Jesús Medina; Itxaso Zubía; Lourdes Sunyer; Enrique Lara-Pezzi; Alejandra Maldonado-Rodríguez; Manuel López-Cabrera; Ricardo Moreno-Otero
Journal:  J Hepatol       Date:  2004-04       Impact factor: 25.083

10.  Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C.

Authors:  H Tanaka; N Fujita; R Sugimoto; N Urawa; S Horiike; Y Kobayashi; M Iwasa; N Ma; S Kawanishi; S Watanabe; M Kaito; Y Takei
Journal:  Br J Cancer       Date:  2008-01-29       Impact factor: 7.640

View more
  2 in total

Review 1.  Nature and Implications of Oxidative and Nitrosative Stresses in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2016-07-13       Impact factor: 3.199

Review 2.  Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions.

Authors:  Albert J Czaja
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.